1.
J Dermatol
; 51(4): e115-e117, 2024 Apr.
Article
En
| MEDLINE
| ID: mdl-37927219
Melanoma , Skin Neoplasms , Uveitis , Humans , Melanoma/drug therapy , Nivolumab/adverse effects , Proto-Oncogene Proteins B-raf/genetics , Skin Neoplasms/drug therapy , Protein Kinase Inhibitors/adverse effects , Uveitis/chemically induced , Uveitis/drug therapy , Mitogen-Activated Protein Kinase Kinases , Antineoplastic Combined Chemotherapy Protocols/pharmacology